Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores

Magnetic Resonance in Medicine

Volumn 46, Issue 6, 2001, Pages 1169-1173

  Sato, Noriko ^a   Kobayashi, Hisataka ^a   Hiraga, Akira ^b   Saga, Tsuneo ^a   Togashi, Kaori ^a   Konishi, Junji ^b   Brechbiel, Martin W ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Dendrimer; Macromolecule; Magnetic resonance imaging; MR contrast agent; Pharmacokinetics

Indexed keywords

BLOOD VESSELS; DENDRIMERS; MACROMOLECULES; MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS;

CONTRAST AGENT; DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; HIGH QUALITY; MOLECULAR SIZE; MR CONTRAST AGENTS; POLYAMIDOAMINE DENDRIMERS; SIGNAL INTENSITIES; SMALL TUMORS;

GADOLINIUM COMPOUNDS;

CONTRAST MEDIUM; DENDRIMER; GADOLINIUM PENTETATE; POLYAMIDOAMINE DENDRIMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CAPILLARY; CARDIOVASCULAR SYSTEM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG EXCRETION; FEMALE; MOLECULAR SIZE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL PROCESSING; TUMOR VASCULARIZATION;

EID: 0035190689     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1314     Document Type: Article

References (17)

1. Assessing tumor angiogenesis using macromolecular MR imaging contrast media
2. Mammary carcinoma model: Correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density
3. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: Preparation and characterization
4. Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents
5. Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance anglography of the body
6. 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with references to their pharmacokinetic properties
7. Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter
8. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns
9. A new macromolecule as a contrast agent for MR angiography: Preparation, properties, and animal studies
10. Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit using a macromolecular contrast agent. Polylysine-gadolinium-DTPA40
11. Scintigraphic detection of neural-cell-derived small-cell lung cancer using glioma-specific antibody
12. 3D MR angiography of intratumoral vasculature using a novel intravascular macromolecular MR contrast agent
13. Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer
14. 99mTc-labeled anti-Tac dsFv
15. 177Lu]alpha-[2-(4-aminophenyl) ethyll-l,4,7,10-tetraaza-cyclodecane-1,4,7,10-tetraacetic acid-CC49 Fab radioimmunoconjugate
16. Aminosyn II effectively blocks renal uptake of 18F-labeled anti-tac disulfide-stabilized Fv
17. A novel intravascular macromolecular MR contrast agent with generation-4 polyamidoamine dendrimer core: Accelerated renal excretion with co-injection of lysine